OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance
Shujing Wang, Jingrui Wang, Zhiqiang Chen, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 119

Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
Zhen Chen, Min Xiong, Jiaqi Tian, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 33

Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers
Manli Zhou, Xiaoyun He, Cheng Mei, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28

Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 10

Mutual regulation of PD-L1 immunosuppression between tumor-associated macrophages and tumor cells: a critical role for exosomes
Banglu Wang, Daoan Cheng, Danyu Ma, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7

Exosome-mediated crosstalk between tumor cells and innate immune cells: implications for cancer progression and therapeutic strategies
Louis Boafo Kwantwi
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 9487-9503
Closed Access | Times Cited: 16

Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
Zhenjun Huang, Ziqi Xiao, Li‐Qing Yu, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104284-104284
Open Access | Times Cited: 6

Tumor‐Associated Macrophages: Key Players in the Non‐Small Cell Lung Cancer Tumor Microenvironment
Tongtong Lv, Rui Fan, Jiaqi Wu, et al.
Cancer Medicine (2025) Vol. 14, Iss. 3
Open Access

Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets
Muath Suliman, Raed Obaid Saleh, M Chandra, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

Exosomal Non-Coding RNAs: Novel Regulators of Macrophage-Linked Intercellular Communication in Lung Cancer and Inflammatory Lung Diseases
Xing-Ning Lai, Jie Zhong, Boyi Zhang, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 536-536
Open Access | Times Cited: 14

Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway
Yazhu Zou, Zitong Zhao, Jingjing Wang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3099-3114
Open Access | Times Cited: 14

Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Exosomes: efficient macrophage-related immunomodulators in chronic lung diseases
Jianxiong Kang, Peiyan Hua, Xiaojing Wu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 4

Mechanistic studies of tumor-associated macrophage immunotherapy
Jiandong Cao, Chengsen Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4

METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer
Xianxiu Ji, Xiaoying Wan, Hui Sun, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway
Tong Pan, Dong-kun Xie, Juan Li, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2500-2500
Open Access | Times Cited: 3

Overcoming EGFR-TKI resistance by targeting the tumor microenvironment
Jinsong Zhang, Natalie I. Vokes, Man Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 3, pp. 151-161
Open Access | Times Cited: 3

The role of exosomes in the tumour microenvironment on macrophage polarisation
Jing Wang, Runmin Long, Yunwei Han
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 6, pp. 188811-188811
Closed Access | Times Cited: 17

Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects
Daoan Cheng, Kele Ge, Xue Yao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
Daoan Cheng, Banglu Wang, Lige Wu, et al.
Medical Oncology (2023) Vol. 40, Iss. 9
Closed Access | Times Cited: 6

miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154906-154906
Closed Access | Times Cited: 6

The therapeutic potential of exosomes in lung cancer
Hongyuan Liang, Lingyun Zhang, Xiangxuan Zhao, et al.
Cellular Oncology (2023) Vol. 46, Iss. 5, pp. 1181-1212
Closed Access | Times Cited: 5

Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities
Sara Hadad, Amirreza Khalaji, Amirreza Jabbaripour Sarmadian, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112406-112406
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top